Türkiye'de sağlık harcamaları ve ekonomik büyüme ilişkisi: VAR analizi
Business & Management Studies: An International Journal · 25.03.2026 · 14 (1) · 1-18
DOI: 10.15295/bmij.v14i1.2677 ↗Kurz gefasst
Fachartikel in der Zeitschrift Business & Management Studies: An International Journal, online erschienen am 25.03.2026. Verfasst von Zeynep Öztürk Yaprak. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This study aims to examine the relationship between health expenditures and economic growth in Türkiye during the period 1975-2022 using time series analysis. The analysis employed a vector autoregressive (VAR) model; dynamic interactions between variables were evaluated using Impulse-Response Functions and Variance Decomposition analyses; and the direction of causality relationships was investigated using the Granger causality test. The findings show that health expenditures have a statistically significant effect on economic growth, explaining approximately 28% of the variance in economic growth. Furthermore, the Granger causality analysis results indicate a unidirectional causal relationship from health expenditures to economic growth. These findings suggest that health expenditures can be considered a supportive and complementary policy tool for long-term economic growth in Türkiye.
Zitieren
APA
Yaprak, Z. Ö. (2026). Türkiye'de sağlık harcamaları ve ekonomik büyüme ilişkisi: VAR analizi. Business & Management Studies: An International Journal, 14(1), 1-18. https://doi.org/10.15295/bmij.v14i1.2677
Vancouver
Yaprak ZÖ. Türkiye'de sağlık harcamaları ve ekonomik büyüme ilişkisi: VAR analizi. Business & Management Studies: An International Journal. 2026;14(1):1-18. doi:10.15295/bmij.v14i1.2677
BibTeX
@article{Yaprak2026,
author = {Yaprak, Zeynep Öztürk},
title = {Türkiye'de sağlık harcamaları ve ekonomik büyüme ilişkisi: VAR analizi},
journal = {Business & Management Studies: An International Journal},
year = {2026},
volume = {14},
number = {1},
pages = {1--18},
doi = {10.15295/bmij.v14i1.2677}
}
EUVIMED